Latest Regulatory News

Euroz Hartleys, acting for Patronus Resources, has launched an unconditional on-market takeover bid for Matsa Resources at A$0.045 per share, aiming to acquire all shares not already controlled. The offer period runs from February 24 to March 24, 2025.

PYC Therapeutics has secured regulatory approval to initiate human trials of PYC-003, a novel drug candidate targeting the root cause of Polycystic Kidney Disease (PKD). Initial safety and efficacy data are expected within 2025, marking a critical step in addressing a disease affecting millions worldwide.

Radiopharm Theranostics' RAD 101 radiotracer demonstrates high sensitivity in detecting brain metastases using a novel PET-mpMRI approach, with a Phase 2b trial now recruiting in the US.

Coolabah Metals Limited is undertaking a $3-4 million capital raise to fund the acquisition of Broken Hill Mines Pty Ltd and its subsidiary, aiming to re-list on the ASX and focus on developing the Rasp and Pinnacles Mines.

Black Dragon Gold has applied for its Salave Gold Project to be designated a Strategic Investment Project under new regional legislation in Asturias, aiming to fast-track development and boost local economic benefits.

Moho Resources has agreed to sell its Empress Springs Project in Western Queensland for $1.258 million, including deferred payments and a retained royalty, as it refocuses its portfolio.

Firebird Metals has inked a non-binding MoU with global mining giant Eramet to supply manganese ore for its upcoming battery-grade manganese plant in China, marking a pivotal step toward production. The agreement aims to evolve into a long-term supply contract by 2026, underpinning Firebird’s growth in the EV battery materials market.

CAR Group Limited has announced a semi-annual ordinary dividend of AUD 0.385 per share, partially franked at 50%, payable in April 2025. Shareholders can opt into a Dividend Reinvestment Plan with no discount, reflecting steady shareholder returns.

Ansell Limited has announced a USD 0.222 per share dividend for the six months ending December 2024, payable in March 2025 with a full dividend reinvestment plan available.

Cleo Diagnostics has responded to an ASX price query following a notable rise in its share price and trading volume, underscoring its patented ovarian cancer detection technology and ongoing U.S. clinical trials.

Xstate Resources has divested its 25% stake in the Crest Jinn assets in Alberta, Canada, opting for a modest royalty interest as it refocuses amid geopolitical and operational uncertainties.

E79 Gold Mines responds to ASX inquiries about recent price and volume spikes, linking market activity to a neighbour's gold find near its Laverton South Project.